Pharma Stocks

US53227K1025) Faces Uncertainty Amid Delisting Risk and Pipeline Focus

aTyr Pharma Inc stock (ISIN: US53227K1025) trades at a subdued market cap of around $131 million as delisting warnings emerge,…

Read More »

CH0012032048) Faces Weekly Pressure Amid Mixed Analyst Views and Divid

Roche Holding AG stock (ISIN: CH0012032048) closed at 320.70 CHF on March 13, 2026, up 0.79% daily but down 8.76%…

Read More »

DE000A1MMCC8) Faces Headwinds Amid German Pharma Wholesale Slowdown

Medios AG stock (ISIN: DE000A1MMCC8) trades under pressure on Xetra as Q4 results reveal margin erosion and slower revenue growth…

Read More »

IL0011408896) Faces Pressure Amid Biotech Sector Volatility

UroGen Pharma Ltd stock (ISIN: IL0011408896) trades under scrutiny as investors weigh clinical progress against cash burn in a tough…

Read More »

Takeda Pharmaceutical (ADR) Stock Steady Amid Pharma Sector Volatility as Investors Eye Pipeline Pro

Takeda Pharmaceutical (ADR) stock (ISIN: US8740602052) holds firm around $17.77, reflecting resilience in a choppy market, with focus shifting to…

Read More »

ES0157097017) Faces Headwinds Amid Dermatology Pipeline Setbacks

Almirall S.A. stock (ISIN: ES0157097017) trades under pressure as investors digest mixed clinical trial results and broader European pharma sector…

Read More »

US7739031091) Faces Pressure Amid R&D Surge and Margin Sq

Regeneron Pharmaceuticals Inc stock (ISIN: US7739031091) dropped 3.6% on March 12, 2026, to $746.61, signaling investor concerns over rising costs…

Read More »

The Bull Case For Daiichi Sankyo Company (TSE:4568) Could Change Following ENHERTU’s Priority Review Success

In March 2026, Daiichi Sankyo and AstraZeneca announced that the U.S. FDA accepted and granted Priority Review to their supplemental…

Read More »

Verrica Pharmaceuticals Q4 Loss Reignites Debate On Path To Sustainable Profitability

Verrica Pharmaceuticals (VRCA) just closed out FY 2025 with Q4 revenue of US$5.1 million and a basic EPS loss of…

Read More »

PreMkt 13 Mar 2026: 0503.HK Lansen Pharma HK +40.94% to HK$1.79: targets

0503.HK stock opened pre-market after a sharp intraday move, trading at HK$1.79, a +40.94% rise versus the previous close, on…

Read More »